𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas

✍ Scribed by I. K. Bukholm; J. M. Nesland

Publisher
Springer
Year
2000
Tongue
English
Weight
157 KB
Volume
436
Category
Article
ISSN
1432-2307

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Reduced p21WAF1/CIP1 expression and p53
Reduced p21WAF1/CIP1 expression and p53 mutation in hepatocellular carcinomas
✍ A M Hui; Y Kanai; M Sakamoto; H Tsuda; S Hirohashi πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 352 KB

RNase H 0 reverse transcriptase (GIBCO-BRL, Gaithersburg, MD). ase chain reaction; SSCP, single-strand conformation polymorphism; mRNA, messenger p21 WAF1/CIP1 messenger RNA (mRNA) was amplified with the follow-RNA; cdk, cyclin dependent kinase.

p21WAF1/Cip1 is associated with cyclin D
p21WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma
✍ Rey, Maria J.; FernΓ‘ndez, Pedro L.; Jares, Pedro; MuΓ±oz, Montserrat; Nadal, Alfo πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 406 KB πŸ‘ 2 views

p21 WAF1/Cip1 is an inhibitor of cdk/cyclin complexes, and thus regulates the cell cycle. p21 is also related to cell differentiation and is regulated by wild-type p53, although p53-independent regulatory pathways have been proposed. In order to analyse p21 expression as well as its relationship wit

Expression of cell-cycle regulatory prot
Expression of cell-cycle regulatory proteins cyclin D1, cyclin E, and their inhibitor p21 WAF1/CIP1 in gastric cancer
✍ MοΏ½ller, Wolfram; Noguchi, Tsuyoshi; Wirtz, Hans-Christian; Hommel, Gerhard; Gabb πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 344 KB πŸ‘ 3 views

The expression and prognostic role of cyclin D1, cyclin E, and p21 (WAF1/CIP1) were immunohistochemically investivated in 413 curatively resected gastric carcinomas. p21 was expressed in 65β€’4 per cent (n=270), cyclin D1 in 23β€’7 per cent (n=98), and cyclin E in 13β€’6 per cent (n=56) of the tumours. Th